1. PO-15: Tinzaparin: a safe choice for lung cancer with VTE and renal impairment. Issue 213 (May 2022) Authors: Dimakakos, E.; Syrigos, K.N.; Vathiotis, I.; Tsiakos, K.; Anagnostakis, M.; Grammoustianou, M.; Gomatou, G.; Sarropoulou, F.; Gerotziafas, G.; Kotteas, E. Journal: Thrombosis research Issue: Issue 213(2022)Supplement 2 Page Start: S17 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Validation of the Khorana score in lung cancer patients: a new predictor of early mortality?. Issue 164 (April 2018) Authors: Vathiotis, I.; Dimakakos, E.; Boura, P.; Ntineri, A.; Charpidou, A.; Gerotziafas, G.T.; Syrigos, K. Journal: Thrombosis research Issue: Issue 164(2018)Supplement 1 Page Start: S233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗